Identification of Affective Disorders During the Diagnosis of Multiple Sclerosis
https://doi.org/10.31550/1727-2378-2023-22-6-35-39
Abstract
Aim: To study emotional disorders and response to stress in patients with multiple sclerosis (MS) at the diagnostic stage.
Design: Comparative prospective study.
Materials and methods. We examined 30 MS patients who were not taking any disease-modifying drugs. The age of patients was 34 ± 9 years; Kurtzke Expanded Disability Status Scale: 1.7 ± 1.3 points. Beck Self-Rating Depression Inventory and V. M. Bekhterev Self-Rating Depression Inventory, State-Trait Anxiety Inventory, Asthenic State Scale, Psychological Diagnostics of Coping Mechanisms, Coping Strategies questionnaire, were used.
Results. MS patients were divided into groups depending on the presence/absence of symptoms of depression (n = 18 and n = 12). The patients with depression had statistically higher (р < 0.05) number of asthenic manifestations and anxiety disorders, emotional releases with fixation on negative events. In order to reduce stress, patients chose to avoid the problem.
Conclusion. Identified emotional disorders aggravate the overall condition of MS patients, reduce stress tolerance and ability to social adaptation; they lead to more complex symptoms and possible disease progression.
About the Author
N. V. Zarubina
Yaroslavl State Medical University
Russian Federation
Russian Federation
5 Revolutionary Str., Yaroslavl, 150000
References
1. Gusev E.I., Boyko A.N. Multiple sclerosis. Academic and research guidance, in 2 volumes. V. 2. М.: Human Health Publishing House; 2020. 572 p. (in Russian)
2. Damulin I.V., Golubeva V.V., Volinets E.I. Chronic inflammatory demyelinating polyradiculoneuropathy with CNS involvement. Neurological Journal. 2001;6(1):36–42. (in Russian)
3. Zavalishin I.A., Spirin N.N., Boyko A.N., Nikitin S.S. Chronic neuroinfections. Moscow: GEOTAR-Media; 2011. 560 p. (in Russian)
4. Pantyuk I.V., Buko N.S., Venglinskaya T.V. Biological and psychological factors affecting rehabilitation potential of patients with multiple sclerosis. In: S.A. Likhachev (ed.). Current problems of neurology and neurosurgery. Minsk: Geoprint; 2008. 10: 185–95. (in Russian)
5. Peresedova A.V., Zavalishin I.A. Coping mechanisms in maltiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(2):17–22. (in Russian)
6. Smulevich A.B. Depressions in somatic and mental disorders. Moscow: Medical Information Agency; 2003. 432 p. (in Russian)
7. Lukina E.V., Kuznetsova D.E. Assessment of anxiety and depression levels in patients with multiple sclerosis. Saratov Journal of Medical Scientific Research. 2012;8(2):484–8. (in Russian)
8. Schmidt T.E. Guidelines from the European Committee for Research and Treatment of Multiple Sclerosis and the European Academy of Neurology (ECTRIMS/EAN) for the treatment of patients with multiple sclerosis. X. Montalblan, R. Gold, A. Thompson et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Europ. J. Neurol., 2018, v. 25, p. 215–237. Neurological Journal. 2018;2:102–4. (in Russian). DOI: 10.18821/1560-9545-2018-23-2-102-104
9. Clark L., Chamberlain S.R., Sahakian B.J. Neurocognitive mechanisms in depression: implications for treatment. Annu. Rev. Neurosci. 2009;32:57–74. DOI: 10.1146/annurev.neuro.31.060407.125618
10. Van Duyse A., Mariman A., Poppe C., Michielsen W. et al. Chronic fatigue syndrome in the psychiatric practice. Acta Neuropsychiatr. 2002;14(3):127–33. DOI: 10.1034/j.1601-5215.2002.140306.x
11. Alekseenko E.V., Sysoeva O.S., Smagina I.V., Fedyanin S.A. Psychological status measurements in patients with multiple sclerosis. Bulletin of Siberian Medicine. 2008;7(5-1):11–3. DOI: 10.20538/1682-0363-2008-5-1-11-12
12. Malygin V.L., Boyko A.N., Konovalova O.E., Pakhtusova E.E., et al. Anxiety and depressive disorders in patients with multiple sclerosis at various stages of the disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2-2):58–63. DOI: 10.17116/jnevro20191192258
13. Schmidt S., Jöstingmeyer P. Depression, fatigue and disability are independently associated with quality of life in patients with multiple sclerosis: Results of a cross-sectional study. Mult. Scler. Relat. Disord. 2019;35:262–9. DOI: 10.1016/j.msard.2019.07.029
14. Reznikova T.N., Seliverstova N.A., Nikiforova I.G., Aroev R.A. Psychological variants of emotional disorders in patients with multiple sclerosis. Bulletin of Psychotherapy. 2012;41(46):99–109. (in Russian)
15. Mohr D.C., Hart S.L., Fonareva I., Tasch E.S. Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult. Scler. 2006;12(2):204–8. DOI: 10.1191/135248506ms1265oa
16. Bobrov A.S., Magonova E.G. Stress-associated depression in outpatient psychiatry. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(7):9– 15. (in Russian) URL: https://www.mediasphera.ru/issues/zhurnalnevrologii-i-psikhiatrii-im-s-s-korsakova/2010/7/downloads/ru/031997-7298201072 (дата обращения — 01.03.2023).
17. Golovkin V.I. Clinical presentation and management of remitting multiple sclerosis. In: Golovkin V.I., Kalinina N.M. (ed.). Immune-mediated remitting multiple sclerosis. St. Petersburg: Roza mira; 2003: 28–34. (in Russian)
18. Gordeeva T.O., Osin E.N., Rasskazova E.I., Sychev O.A., et al. Diagnostics of coping strategies: COPE questionnaire adaptation. In: Kryukova T.L., Saporovskaya M.V., Khazova S.A. (ed.). Psychology of stress and coping in modern Russian society: Materials of the II International Scientific and Practical Conference. Kostroma: Publishing House of N.A. Nekrasov Kostroma State University; 2010. Т. 2: 195–7. (in Russian)
19. Alsaadi T., Hammasi K.E., Shahrour T.M., Shakra M. et al. Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis — United Arab Emirates. Neurol. Int. 2017;9(4):7343. DOI: 10.4081/ni.2017.7343
20. Zorzon M., de Masi R., Nasuelli D., Ukmar M. et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J. Neurol. 2001;248(5):416–21. DOI: 10.1007/s004150170184
21. Krasnov V.N. Problems of modern diagnostics of depression. S.S. Korsakov Journal of Neurology and Psychiatry. Special issue. 2012;112(11-2):3–10. (in Russian)
22. Hasselmann H., Bellmann-Strobl J., Ricken R., Oberwahrenbrock T. et al. Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression. Mult. Scler. 2016;22(11):1476–84. DOI: 10.1177/1352458515622826
23. Zarubina N.V., Spirin N.N. Coping strategies in patients with multiple sclerosis and depression. Vestnik Ivanovskoj Medicinskoj Akademii. 2020;25(1):31–5. (in Russian)
24. Rasskazova E.I. Coping strategy and personal potential. In: Rasskazova E.I., Gordeeva T.O.; Leontiev D.A. (ed.). Personal potential: structure and diagnostics. Moscow: Smysl; 2011: 267–99. (in Russian)
25. Lazarus R., Folkman S. Ways of Coping Questionnaire. 1988. URL: https://psytests.org/coping/lazarus.html (дата обращения — 01.03.2023).
26. Akintseva Yu.V., Trushnikova T.N., Baydina T.V. Effect of fatigue syndrome on the quality of life of patients with multiple sclerosis. Neurology Bulletin. 2010;XLII(1):132–3. (in Russian)
27. Carta M.G., Paribello P., Anastasia A., De Berardis D. et al. Pharmacological management of depression in patients with multiple sclerosis. Expert Opin. Pharmacother. 2018;19(14):1533– 40. DOI: 10.1080/14656566.2018.1516207
28. Feinstein A., Feinstein K. Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression. J. Affect. Disord. 2001;66(2–3):193–8. DOI: 10.1016/s0165-0327(00)00298-6
Review
For citations:
Zarubina N.V. Identification of Affective Disorders During the Diagnosis of Multiple Sclerosis. Title. 2023;22(6):35-39. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-6-35-39
Views:
11
Email this article 